Lars Siim Madsen

3.4k citations

20 papers · 2.6k indexed · 1 hit paper · h-index 12

Co-authors: Lars Fugger Arne Svejgaard Helge Scott Knut E. A. Lundin Roman Körner Hanne Quarsten Øyvind Molberg Stephen N. McAdam
Topics: Oral Health Pathology and Treatment (9 papers)Immunotherapy and Immune Responses (6 papers)T-cell and B-cell Immunology (5 papers)
Cited by: Gastroenterology Immunology Pathology and Forensic Medicine
Journals: Nature Proceedings of the National Academy of Sciences Nature Medicine
Partner nations: Denmark United Kingdom United States

In The Last Decade

Lars Siim Madsen

20 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

1998 914 citations Øyvind Molberg, Stephen N. McAdam et al. Nature Medicine profile →

Peers

Countries citing papers authored by Lars Siim Madsen

Since Specialization

Citations

This map shows the geographic impact of Lars Siim Madsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Siim Madsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Siim Madsen more than expected).

Fields of papers citing papers by Lars Siim Madsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Siim Madsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Siim Madsen. The network helps show where Lars Siim Madsen may publish in the future.

Co-authorship network of co-authors of Lars Siim Madsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Siim Madsen. A scholar is included among the top collaborators of Lars Siim Madsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Siim Madsen. Lars Siim Madsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Tissue-Engineered Model of T-Cell–Mediated Oral Mucosal Inflammatory Disease 2024 ·Journal of Investigative Dermatology ·(unknown),(unknown),(unknown),Lars Siim Madsen,Craig Murdoch,Helen Colley	2
2	Bioactive Protein and Peptide Release from a Mucoadhesive Electrospun Membrane 2023 ·Biomedical Materials & Devices ·(unknown),Craig Murdoch,Paul V. Hatton,Lars Siim Madsen,(unknown),Sebastian G. Spain,Helen Colley	4
3	Electrospun patch delivery of anti-TNFα F(ab) for the treatment of inflammatory oral mucosal disease 2022 ·Journal of Controlled Release ·(unknown),(unknown),Helen Colley,(unknown),Lars Siim Madsen,Paul V. Hatton,Sebastian G. Spain,Craig Murdoch	20
4	EFFICACY AND SAFETY OF A NOVEL MUCOADHESIVE CLOBETASOL PATCH FOR TREATMENT OF ORAL LICHEN PLANUS 2022 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·Michael T. Brennan,Lars Siim Madsen,Deborah Saunders,Joel J. Napeñas,Richeal Ní Ríordáin,Anne Marie Lynge Pedersen,Stefano Fedele,Richard J. Cook,Rafik Abdelsayed,Vidya Sankar,Thomas Ruzicka	1
5	Oral lichen planus clinician reported outcome measure: Development, content validity, and further development 2022 ·Oral Diseases ·Michael T. Brennan,Richeal Ní Ríordáin,Leslie Long‐Simpson,(unknown),Marcela Lizano,Lars Siim Madsen	2
6	Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases 2021 ·European Journal Of Oral Sciences ·Zafar Said,Craig Murdoch,J. Mølholm Hansen,Lars Siim Madsen,Helen Colley	16
7	Novel Oral Lichen Planus Symptom Severity Measure for assessing patients’ daily symptom experience 2019 ·Oral Diseases ·Laurie B. Burke,Michael T. Brennan,Richeal Ní Ríordáin,Lars Siim Madsen	9
8	Pre-clinical evaluation of novel mucoadhesive bilayer patches for local delivery of clobetasol-17-propionate to the oral mucosa 2018 ·Biomaterials ·Helen Colley,(unknown),(unknown),Sarah R. Baker,(unknown),Jakob Møller Hansen,Lars Siim Madsen,Martin H. Thornhill,Paul V. Hatton,Craig Murdoch	99
9	Novel Bilayer Mucoadhesive Patches for Delivery of Clobetasol-17-Propionate to the Oral Mucosa to Treat Oral Lichen Planus; an in Vitro and in Vivo Evaluation 2018 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·Helen Colley,(unknown),(unknown),Sarah R. Baker,(unknown),J. Mølholm Hansen,Lars Siim Madsen,Martin H. Thornhill,Paul V. Hatton,Craig Murdoch	1
10	The Rivelin Patch—A New Treatment Strategy for Oral Lichen Planus 2018 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·Thomas Ruzicka,Marlene Seegräber,Thomas Bieber,Bernhard Homey,Richeal Ní Ríordáin,Lars Siim Madsen,Jens Hansen	5
11	The Small Molecule NS11021 Is a Potent and Specific Activator of Ca2+-Activated Big-Conductance K+ Channels 2007 ·Molecular Pharmacology ·Bo Hjorth Bentzen,Antônio Egídio Nardi,Kirstine Calløe,Lars Siim Madsen,Søren‐Peter Olesen,Morten Grunnet	100
12	Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca²⁺‐activated K⁺channels 2007 ·British Journal of Pharmacology ·Charlotte Hougaard,Birgitte L. Eriksen,Sine W. Jørgensen,Tina H. Johansen,Tino Dyhring,Lars Siim Madsen,Dorte Strøbæk,Palle Christophersen	132
13	Functional epistasis on a common MHC haplotype associated with multiple sclerosis 2006 ·Nature ·Jon Waarst Gregersen,Kamil R. Kranc,Xiayi Ke,Pia Svendsen,Lars Siim Madsen,Allan Randrup Thomsen,Lon R. Cardon,John I. Bell,Lars Fugger	154
14	Blockade of Ca²⁺‐activated K⁺ channels in T cells: an option for the treatment of multiple sclerosis? 2005 ·European Journal of Immunology ·Lars Siim Madsen,Palle Christophersen,Søren‐Peter Olesen	9
15	A functional and structural basis for TCR cross-reactivity in multiple sclerosis 2002 ·Nature Immunology ·Heather Lang,Helle J. Jacobsen,Shinji Ikemizu,C. Evalena Andersson,Karl Harlos,Lars Siim Madsen,Peter Hjorth,Leif Søndergaard,Arne Svejgaard,Kai W. Wucherpfennig,David I. Stuart,John I. Bell,E. Yvonne Jones,Lars Fugger	441
16	Mice lacking all conventional MHC class II genes 1999 ·Proceedings of the National Academy of Sciences ·Lars Siim Madsen,Nathalie Labrecque,Jan Engberg,Andrée Dierich,Arne Svejgaard,Christophe Benoıst,Diane Mathis,Lars Fugger	274
17	A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor 1999 ·Nature Genetics ·Lars Siim Madsen,Ellen Andersson,Liselotte Jansson,Michelle Krogsgaard,Claus B. Andersen,Jan Engberg,J L Strominger,Arne Svejgaard,J. Peter Hjorth,Rikard Holmdahl,Kai W. Wucherpfennig,Lars Fugger	264
18	Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac diseasebreakdown → 1998 ·Nature Medicine ·Øyvind Molberg,Stephen N. McAdam,Roman Körner,Hanne Quarsten,(unknown),Lars Siim Madsen,Lars Fugger,Helge Scott,Ove Norén,Peter Roepstorff,Knut E. A. Lundin,Hans Sjöström,Ludvig M. Sollid	914
19	Functional characterization of HLA‐DRA11 0101/ DRB1* 0401 molecules expressed in Drosophila melanogaster cells 1998 ·Tissue Antigens ·Bjarke Endel Hansen,Ellen Andersson,Lars Siim Madsen,Jan Engberg,Leif Søndergaard,Arne Svejgaard,Lars Fugger	15
20	Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice 1998 ·Proceedings of the National Academy of Sciences ·Ellen Andersson,Bjarke Endel Hansen,Helle J. Jacobsen,Lars Siim Madsen,Claus B. Andersen,Jan Engberg,Jonathan B. Rothbard,(unknown),Vivianne Malmström,Rikard Holmdahl,Arne Svejgaard,Lars Fugger	128

About Lars Siim Madsen

Lars Siim Madsen is a scholar working on Periodontics, Immunology and Pharmaceutical Science, having authored 20 papers that have together received 2.6k indexed citations. Recurring topics across this work include Oral Health Pathology and Treatment (9 papers), Immunotherapy and Immune Responses (6 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Gastroenterology (803 citations), Immunology (1.1k citations) and Pathology and Forensic Medicine (495 citations). Lars Siim Madsen has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Lars Fugger, Arne Svejgaard, Helge Scott, Knut E. A. Lundin, Roman Körner, Hanne Quarsten, Øyvind Molberg, Stephen N. McAdam, Ludvig M. Sollid and Ove Norén. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact